News provided by eMed May 05, 2025, 13:02 ET Partnership provides virtual clinical support with data driven measurement to improve adherence for obesity management MIAMI, May 5, 2025 /PRNewswire/ -- eMed, the leading Population Health technology platform in remote chronic care management and 24/7/365 live care, today announced an industry-changing collaboration with leading global professional services firm, Aon , to provide GLP-1 obesity management services for the company's U.S
Quantification of the average fluorescence intensity per unit area showed that bacteriocytes of anti- syeA -treated aphids exhibited elevated lysosomal activity (MannWhitney U -test, U = 10,032, n = 147 control, 158 treated, P = 0.0324) (Fig
Is GHRP-6 used for therapeutic purposes
Reconstitution: 3.0 mL per 10 mg vial (3.33 mg/mL) for accurate unit measurements